Literature DB >> 23908383

A "three-plus-one" evaluation model for clinical research management.

David M Dilts1.   

Abstract

Clinical research management (CRM) is a critical resource for the management of clinical trials and it requires proper evaluation. This article advances a model of evaluation that has three local levels, plus one global level, for evaluating the value of CRM. The primary level for evaluation is that of the study or processes level. The managerial or aggregate level concerns management of the portfolio of trials under the control of the CRM office. The third, often overlooked level of evaluation, is the strategic level, whose goal is encapsulated in the phrase, "doing the right trials, while doing trials right." The global ("plus one") evaluation level concerns the need to evaluate the ever-increasing number of multi-institutional and multinational studies. As there are host of evaluation metrics, this article provides representative examples of metrics at each level and provides methods that can aid in the selecting appropriate metrics for an organization.

Keywords:  CRM value; global evaluation; managerial evaluation; strategic evaluation

Mesh:

Year:  2013        PMID: 23908383     DOI: 10.1177/0163278713499019

Source DB:  PubMed          Journal:  Eval Health Prof        ISSN: 0163-2787            Impact factor:   2.651


  3 in total

1.  21 Code of Federal Regulations Part 11-Compliant Digital Signature Solution for Cancer Clinical Trials: A Single-Institution Feasibility Study.

Authors:  Therica M Miller; Jenny Lester; Lorna Kwan; Megha D Tandel; Beth Y Karlan; B J Rimel
Journal:  JCO Clin Cancer Inform       Date:  2020-09

2.  Trust in Community-Engaged Research Partnerships: A Methodological Overview of Designing a Multisite Clinical and Translational Science Awards (CTSA) Initiative.

Authors:  Mimi M Kim; Ann Cheney; Anita Black; Roland J Thorpe; Crystal Wiley Cene; Guarav J Dave; Jennifer Schaal; Stefanie Vassar; Corrine Ruktanonchai; Leah Frerichs; Tiffany Young; Jennifer Jones; Jessica Burke; Deepthi Varma; Catherine Striley; Linda Cottler; Arleen Brown; Greer Sullivan; Giselle Corbie-Smith
Journal:  Eval Health Prof       Date:  2019-01-06       Impact factor: 2.651

3.  Activating clinical trials: a process improvement approach.

Authors:  Diego A Martinez; Athanasios Tsalatsanis; Ali Yalcin; José L Zayas-Castro; Benjamin Djulbegovic
Journal:  Trials       Date:  2016-02-24       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.